{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:35:31Z","timestamp":1774665331523,"version":"3.50.1"},"reference-count":27,"publisher":"BMJ","issue":"7018","license":[{"start":{"date-parts":[[1995,12,2]],"date-time":"1995-12-02T00:00:00Z","timestamp":817862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1995,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    : To estimate the cost effectiveness of different antenatal screening programmes for cystic fibrosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting<\/jats:bold>\n                    : Antenatal clinics and general practices in the United Kingdom.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design<\/jats:bold>\n                    : Four components of the screening process were identified: information giving, DNA testing, genetic counselling, and prenatal diagnosis. The component costs were derived from the literature and from a pilot screening study in Yorkshire. The cost of a given screening programme was then obtained by summing the components according to the specific screening strategy adopted (sequential and couple), the proportion of carriers detected by the DNA test, and the uptake of screening. Baseline assumptions were made about the proportion with missing information on carrier status from previous pregnancies (20%), the proportion changing partners between pregnancies (20%), and the uptake of prenatal diagnosis (100%). Sensitivity analysis was performed by varying these assumptions.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Main outcome measure<\/jats:bold>\n                    : Cost per affected pregnancy detected.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : Under the baseline assumptions sequential screening costs between pounds sterling40000 and pounds sterling90000 per affected pregnancy detected, depending on the carrier detection rate and uptake. Couple screening was more expensive, ranging from pounds sterling46000 to pounds sterling104000. From the sensitivity analysis a 10% change in the assumed proportion with missing information from a previous pregnancy alters the cost by pounds sterling4000; a 10% change in the proportion with new partners has a similar effect but only for couple screening; and cost will change directly in proportion to the uptake of prenatal diagnosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    : While economic analysis cannot determine screening policy, the paper provides the NHS with the information on cost effectiveness needed to inform decisions on the introduction of a screening service for cystic fibrosis.\n                  <\/jats:p>","DOI":"10.1136\/bmj.311.7018.1460","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:38:20Z","timestamp":1319744300000},"page":"1460","source":"Crossref","is-referenced-by-count":37,"title":["Cost effectiveness of antenatal screening for cystic fibrosis"],"prefix":"10.1136","volume":"311","author":[{"given":"H S","family":"Cuckle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G A","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T A","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Quirke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1995,12,2]]},"reference":[{"key":"2025122209025188000_311.7018.1460.1","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/bmj.297.6663.1599","article-title":"Cystic fibrosis in the United Kingdom 1977\u201385: an improving picture.","volume":"297","year":"1988","journal-title":"BMJ"},{"key":"2025122209025188000_311.7018.1460.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2772657"},{"key":"2025122209025188000_311.7018.1460.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911"},{"key":"2025122209025188000_311.7018.1460.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.2570460"},{"key":"2025122209025188000_311.7018.1460.5","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90476-J"},{"key":"2025122209025188000_311.7018.1460.6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/bmj.306.6892.1580","article-title":"Cystic fibrosis carrier testing in early pregnancy by general practitioners.","volume":"306","author":"Harris","year":"1993","journal-title":"BMJ"},{"key":"2025122209025188000_311.7018.1460.7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0140-6736(93)92403-G","article-title":"Couple screening for cystic fibrosis.","volume":"342","author":"Wald","year":"1993","journal-title":"Lancet"},{"key":"2025122209025188000_311.7018.1460.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6942.1459"},{"key":"2025122209025188000_311.7018.1460.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6976.353"},{"key":"2025122209025188000_311.7018.1460.10","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92605-2"},{"key":"2025122209025188000_311.7018.1460.11","unstructured":"Office of Population Censuses and Surveys .National population projections. London: HMSO,1995. (Series PP2 No 19.)"},{"key":"2025122209025188000_311.7018.1460.12","first-page":"354","article-title":"Worldwide survey of the (Delta)F508 mutation.","volume":"47","year":"1990","journal-title":"Am J Hum Genet"},{"key":"2025122209025188000_311.7018.1460.13","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.28.5.317"},{"key":"2025122209025188000_311.7018.1460.14","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.9.642"},{"key":"2025122209025188000_311.7018.1460.15","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.4.316"},{"key":"2025122209025188000_311.7018.1460.16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bmj.308.6942.1462","article-title":"Active cascade testing for carriers of cystic fibrosis gene.","volume":"308","author":"Super","year":"1994","journal-title":"BMJ"},{"key":"2025122209025188000_311.7018.1460.17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.31.7.545"},{"key":"2025122209025188000_311.7018.1460.18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/bmj.302.6785.1133","article-title":"Appraisal of a new scheme for prenatal screening for Down's syndrome.","volume":"302","author":"Sheldon","year":"1991","journal-title":"BMJ"},{"key":"2025122209025188000_311.7018.1460.19","first-page":"175","article-title":"An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.","volume":"15","author":"Shackley","year":"1993","journal-title":"J Public Health Med"},{"key":"2025122209025188000_311.7018.1460.20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/096914139400100109","article-title":"Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne).","volume":"1","author":"Piggott","year":"1994","journal-title":"Journal of Medical Screening"},{"key":"2025122209025188000_311.7018.1460.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9378(12)90875-3","article-title":"Reporting the results of cystic fibrosis carrier screening.","volume":"168","author":"Asch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2025122209025188000_311.7018.1460.22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hec.4730030104","article-title":"Costbenefit analysis of a national screening programme for cystic fibrosis in a Israeli population.","volume":"3","author":"Ginsberg","year":"1994","journal-title":"Health Economics"},{"key":"2025122209025188000_311.7018.1460.23","first-page":"903","article-title":"The cost-effectiveness of prenatal carrier screening for cystic fibrosis.","volume":"84","author":"Lieu","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2025122209025188000_311.7018.1460.24","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.9.684"},{"key":"2025122209025188000_311.7018.1460.25","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199105000-00007"},{"key":"2025122209025188000_311.7018.1460.26","first-page":"873","volume":"37","author":"Mooney","year":"1993","journal-title":"Ante-natal screening: what constitutes \u2018benefit'? Soc Sci Med"},{"key":"2025122209025188000_311.7018.1460.27","first-page":"282","article-title":"Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay.","volume":"32","author":"Miedzybrodzka","year":"1995","journal-title":"Journal of Medical Screening"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.311.7018.1460","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.311.7018.1460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:03:06Z","timestamp":1766422986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.311.7018.1460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12,2]]},"references-count":27,"journal-issue":{"issue":"7018","published-online":{"date-parts":[[1995,12,2]]},"published-print":{"date-parts":[[1995,12,2]]}},"alternative-id":["10.1136\/bmj.311.7018.1460"],"URL":"https:\/\/doi.org\/10.1136\/bmj.311.7018.1460","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12,2]]}}}